Poviztra FLXT 0.25mg 1.5ml Injection 1S
Rs. 3,799.05
Title
Poviztra FLXT 0.25mg 1.5ml Injection 1S
Prescription drug
Expiry
:
31-05-2028
About: Poviztra FLXT 0.25mg contains Semaglutide 0.25mg, a GLP-1 receptor agonist for weight management and type 2 diabetes in once-weekly injection.Usage Instructions: Inject subcutaneously once weekly on same day each week. Rotate injection sites (abdomen, thigh, upper arm). Start with 0.25mg for 4 weeks then titrate.Benefits: Promotes weight loss, improves glycemic control, reduces appetite, once-weekly dosing, cardiovascular benefits, low hypoglycemia risk.How it Works: Semaglutide mimics GLP-1 hormone, enhancing glucose-dependent insulin secretion, suppressing glucagon, slowing gastric emptying, reducing appetite.Side Effects: Nausea, vomiting, diarrhea, constipation, abdominal pain, decreased appetite, injection site reactions. Serious: pancreatitis, gallbladder disease, kidney problems.Safety Advice: Not for type 1 diabetes or DKA. Contraindicated in personal/family history of medullary thyroid carcinoma or MEN 2. Monitor for pancreatitis symptoms. Use caution in renal impairment.Storage: Refrigerate at 2-8°C. Do not freeze. After first use, can store at room temperature (below 30°C) for up to 6 weeks. Protect from light.
₹3,799.05
MRP: ₹3,999.00
Save ₹199.95
(5%)
Inclusive of all taxes
Quantity
Fresh Stock
Guaranteed
Guaranteed
Secure & Hygienic
Packaging
Packaging
Verified & Trusted
Supplements
Supplements
Secure
Payment
Payment
About: Poviztra FLXT 0.25mg contains Semaglutide 0.25mg, a GLP-1 receptor agonist for weight management and type 2 diabetes in once-weekly injection.Usage Instructions: Inject subcutaneously once weekly on same day each week. Rotate injection sites (abdomen, thigh, upper arm). Start with 0.25mg for 4 weeks then titrate.Benefits: Promotes weight loss, improves glycemic control, reduces appetite, once-weekly dosing, cardiovascular benefits, low hypoglycemia risk.How it Works: Semaglutide mimics GLP-1 hormone, enhancing glucose-dependent insulin secretion, suppressing glucagon, slowing gastric emptying, reducing appetite.Side Effects: Nausea, vomiting, diarrhea, constipation, abdominal pain, decreased appetite, injection site reactions. Serious: pancreatitis, gallbladder disease, kidney problems.Safety Advice: Not for type 1 diabetes or DKA. Contraindicated in personal/family history of medullary thyroid carcinoma or MEN 2. Monitor for pancreatitis symptoms. Use caution in renal impairment.Storage: Refrigerate at 2-8°C. Do not freeze. After first use, can store at room temperature (below 30°C) for up to 6 weeks. Protect from light.